RE: Scancell Performance30 Dec 2020 17:15
Will be fine for the patient investors.
SCLP has all what is required to produce the goods..
Arrays of Top scientists with PHDs, plans to execute, designed products in house, unique and innovative biotechnology in desperate needs to fight cancers and other medical conditions, they have pile of cash to see them through initial trials and partnerships ,supported by rich specialists healthcare funds....and directors interest aligned with us the minority shareholders in comparison.
What not to like...
All is required is a little patience....